Kurt Schrader: “And to the Committee, it is just so emblematic of the lack of sensitivity that BIA/BIE have toward Indian Country.”

The success that WRDA has had during these divided times is a testament to the committee's willingness to work across the aisle.

The absence of a long-term sustainable funding source for the Highway Trust Fund is deeply concerning.

The BIOSIM Act is a commonsense approach to increase the utilization of biosimilars in this country.

That prescription drug bill is an excellent, excellent balance between H.R. 3 and what others would perhaps like to do.